David Perdue bought Bristol-Myers Squibb Company (NYSE: BMY)
David Perdue (R-GA), a U.S. Senator, has disclosed 7 trades in Bristol-Myers Squibb Company (BMY) since 2016, 3 purchases and 4 sales, worth an estimated $154K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: David Perdue bought $15,001 - $50,000 of Bristol-Myers Squibb Company (NYSE: BMY) on July 15, 2019. Since that trade, BMY is up +84.34% against the S&P 500 up +167.95%, an outperformance of -83.61%.
Across these filings, David Perdue has been a net seller of BMY (a buy-to-sell ratio of 0.75). The most recent disclosed BMY transaction shown was dated April 16, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
David Perdue's BMY trades vs the price
BMY is up +84.34% since David Perdue bought on July 15, 2019, versus +167.95% for the S&P 500.
Performance since this trade
All David Perdue BMY trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
David Perdue & BMY trading FAQ
Is it legal for David Perdue to trade Bristol-Myers Squibb Company (BMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Bristol-Myers Squibb Company (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did David Perdue buy BMY?
David Perdue disclosed a purchase of $15,001 - $50,000 of Bristol-Myers Squibb Company (BMY) on July 15, 2019, according to public STOCK Act filings.
How has BMY performed since David Perdue's trade?
Since David Perdue bought BMY on July 15, 2019, the stock is up +84.34%, versus +167.95% for the S&P 500 over the same period, an outperformance of -83.61%.
How many times has David Perdue traded BMY?
David Perdue has disclosed 7 BMY trades since 2016 (3 purchases and 4 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMY trades?
Quantellect tracks every disclosed congressional trade in Bristol-Myers Squibb Company (BMY) on the Bristol-Myers Squibb Company congressional trading page, which aggregates filings across all members of Congress.
David Perdue's BMY tradesAll congressional filings for Bristol-Myers Squibb CompanyDavid Perdue's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.